Literature DB >> 8073279

Cholera vaccines: fighting an ancient scourge.

J J Mekalanos1, J C Sadoff.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8073279     DOI： 10.1126/science.8073279

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells.

Authors:  S F Mel; K J Fullner; S Wimer-Mackin; W I Lencer; J J Mekalanos
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 2.  Going against the grain: chemotaxis and infection in Vibrio cholerae.

Authors:  Susan M Butler; Andrew Camilli
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

3.  A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.

Authors:  M K Waldor; H Tschäpe; J J Mekalanos
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

4.  Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae.

Authors:  K Skorupski; R K Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.

Authors:  Haopeng Rui; Jennifer M Ritchie; Roderick T Bronson; John J Mekalanos; Yuanxing Zhang; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  Epidemic cholera in the new world: translating field epidemiology into new prevention strategies.

Authors:  R V Tauxe; E D Mintz; R E Quick
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

7.  Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.

Authors:  J Murray; D A McFarland; R J Waldman
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

8.  CTXphi immunity: application in the development of cholera vaccines.

Authors:  H H Kimsey; M K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Deletion of a Vibrio cholerae ClC channel results in acid sensitivity and enhanced intestinal colonization.

Authors:  Yanpeng Ding; Matthew K Waldor
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.